Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06938243

Wether VNS in Early Stage (3 Months) is Safe and More Beneficial for Post-stroke Motor Rehabilitation

The Comparison of Safety and Treatment Results Between Early (<6 Months) and Late (> 6 Months) Vagus Stimulation for Post-stroke Motor Rehabilitation: a Randomized Clinical Trial

Status
Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Qilu Hospital of Shandong University · Academic / Other
Sex
All
Age
30 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Upper-extremity impairment after stroke remains a major therapeutic challenge and a target of neuromodulation treatment efforts. In previous study, Vagus nerve stimulation was constricted to patients 9 months after stroke. In this randomized phase I trial, we would apply vagus nerve stimulation in an early stage (\<6 month) and observe its theraputic effect on motor function after ischaemic Stroke.We hypothesized that the early stimulation could be safe and more beneficial compared to stimulation in late stage.

Conditions

Interventions

TypeNameDescription
DEVICEVagus Nerve Stimulation in early stageDevice implantation was done under general anaesthesia. A horizontal neck crease incision was created left of the midline at the level of the cricoid cartilage. After the vagus nerve was identified, the stimulation lead was wrapped around the vagus nerve. The lead was then tunnelled subcutaneously to the pulse generator device which was contained in a subcutaneous pocket in the pectoral region.
DEVICEVagus Nerve Stimulation in late stageDevice implantation was done under general anaesthesia. A horizontal neck crease incision was created left of the midline at the level of the cricoid cartilage. After the vagus nerve was identified, the stimulation lead was wrapped around the vagus nerve. The lead was then tunnelled subcutaneously to the pulse generator device which was contained in a subcutaneous pocket in the pectoral region

Timeline

Start date
2025-05-01
Primary completion
2026-05-01
Completion
2026-12-30
First posted
2025-04-22
Last updated
2025-04-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06938243. Inclusion in this directory is not an endorsement.